Congleton Jon — SEC Form 4 filings

SEC reporting owner CIK 1644975. 21 Form 4 filings on record with FilingPulse; latest filed 2026-07-15.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2024-02-15 to 2026-07-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mineralys Therapeutics, Inc. (MLYS)Chief Executive Officer, Director1828 legs · 610,429 sh · $17,423,0596
IMMUNIC, INC. (IMUX)Director22
Avalyn Pharma Inc. (AVLN)Director11

Form 4 filings — Congleton Jon

FiledFormIssuerReported transactionsSource
2026-07-154Mineralys Therapeutics, Inc. (MLYS)Sale (S): 10,700 @ $27.24EDGAR
2026-07-074IMMUNIC, INC. (IMUX)Grant/award (A): 25,370 (derivative) @ $0EDGAR
2026-06-304Mineralys Therapeutics, Inc. (MLYS)Sale (S): 58,000 @ $25.94 · Sale (S): 17,000 @ $26.82EDGAR
2026-06-294IMMUNIC, INC. (IMUX)Grant/award (A): 50,740 (derivative) @ $0EDGAR
2026-05-014Avalyn Pharma Inc. (AVLN)Grant/award (A): 26,978 (derivative) @ $0EDGAR
2026-04-154Mineralys Therapeutics, Inc. (MLYS)Sale (S): 15,730 @ $26.83EDGAR
2026-04-024Mineralys Therapeutics, Inc. (MLYS)Sale (S): 19,364 @ $25.50 · Sale (S): 55,183 @ $26.54 · Sale (S): 453 @ $27.05EDGAR
2026-02-204Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 140,900 @ $0 · Grant/award (A): 187,900 (derivative) @ $0EDGAR
2026-01-134Mineralys Therapeutics, Inc. (MLYS)Sale (S): 9,119 @ $32.21 · Sale (S): 7,117 @ $33.15EDGAR
2025-11-244Mineralys Therapeutics, Inc. (MLYS)Option exercise (M): 24,082 @ $0.54 · Option exercise (M): 24,082 (derivative) @ $0EDGAR
2025-11-134Mineralys Therapeutics, Inc. (MLYS)Sale (S): 12,806 @ $41.64 · Sale (S): 8,862 @ $42.31 · Sale (S): 4,000 @ $43.50 · Sale (S): 29,207 @ $45.20 · Sale (S): 112,275 @ $45.83 · Sale (S): 32,850 @ $46.89EDGAR
2025-10-154Mineralys Therapeutics, Inc. (MLYS)Sale (S): 13,548 @ $42.63 · Sale (S): 1,552 @ $43.03EDGAR
2025-07-154Mineralys Therapeutics, Inc. (MLYS)Sale (S): 15,884 @ $14.51EDGAR
2025-04-154Mineralys Therapeutics, Inc. (MLYS)Sale (S): 15,319 @ $12.19EDGAR
2025-02-244Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 570,000 (derivative) @ $0EDGAR
2025-01-154Mineralys Therapeutics, Inc. (MLYS)Sale (S): 18,333 @ $9.06EDGAR
2024-10-154Mineralys Therapeutics, Inc. (MLYS)Sale (S): 15,271 @ $13.52EDGAR
2024-07-124Mineralys Therapeutics, Inc. (MLYS)Sale (S): 15,746 @ $13.34EDGAR
2024-06-204Mineralys Therapeutics, Inc. (MLYS)Sale (S): 17,766 @ $12.25 · Sale (S): 16,607 @ $11.99 · Sale (S): 14,940 @ $11.73EDGAR
2024-06-144Mineralys Therapeutics, Inc. (MLYS)Sale (S): 16,607 @ $12.77 · Sale (S): 39,961 @ $12.74 · Sale (S): 16,229 @ $12.52EDGAR
2024-02-154Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 425,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1644975 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →